J
Jeevanantham Rajeswaran
Researcher at Cleveland Clinic
Publications - 137
Citations - 8723
Jeevanantham Rajeswaran is an academic researcher from Cleveland Clinic. The author has contributed to research in topics: Mitral valve & Aortic valve. The author has an hindex of 44, co-authored 121 publications receiving 7661 citations. Previous affiliations of Jeevanantham Rajeswaran include Cleveland Clinic Lerner Research Institute.
Papers
More filters
Journal ArticleDOI
Tricuspid valve repair: Durability and risk factors for failure
Patrick M. McCarthy,Sunil K. Bhudia,Jeevanantham Rajeswaran,Katherine J. Hoercher,Bruce W. Lytle,Delos M. Cosgrove,Eugene H. Blackstone +6 more
TL;DR: Tricuspid valve annuloplasty did not consistently eliminate functional regurgitation, and across time regurgitated increased importantly after Peri-Guard and De Vega annuloplasties, and these repair techniques should be abandoned.
Journal ArticleDOI
Recurrent mitral regurgitation after annuloplasty for functional ischemic mitral regurgitation
Edwin C. McGee,A. Marc Gillinov,Eugene H. Blackstone,Jeevanantham Rajeswaran,Gideon Cohen,Farzad Najam,Takahiro Shiota,Joseph F. Sabik,Bruce W. Lytle,Patrick M. McCarthy,Delos M. Cosgrove +10 more
TL;DR: Although initial mitral valve replacement would eliminate the risk of postoperative mitral regurgitation, this strategy has been associated with reduced survival, and the development of additional techniques is necessary to achieve more secure repair of functional ischemic mitral Regurgitation.
Journal ArticleDOI
Impact of mitral valve annuloplasty combined with revascularization in patients with functional ischemic mitral regurgitation.
Tomislav Mihaljevic,Buu Khanh Lam,Jeevanantham Rajeswaran,Masami Takagaki,Michael S. Lauer,A. Marc Gillinov,Eugene H. Blackstone,Bruce W. Lytle +7 more
TL;DR: CABG + MV annuloplasty reduces postoperative MR and improves early symptoms compared with CABG alone, but it does not improve long-term functional status or survival in patients with severe functional ischemic MR.
Journal ArticleDOI
Long-Term Durability of Bioprosthetic Aortic Valves: Implications From 12,569 Implants
Douglas R. Johnston,Edward G. Soltesz,Nakul Vakil,Jeevanantham Rajeswaran,Eric E. Roselli,Joseph F. Sabik,Nicholas G. Smedira,Lars G. Svensson,Bruce W. Lytle,Eugene H. Blackstone +9 more
TL;DR: Durability of the Carpentier-Edwards PERIMOUNT aortic valve is excellent even in younger patients, and strategies to reduce early postoperative AV gradients, such as root enlargement or more efficient prostheses, should be considered.
Journal ArticleDOI
Transcatheter (TAVR) versus surgical (AVR) aortic valve replacement: Occurrence, hazard, risk factors, and consequences of neurologic events in the PARTNER trial
D. Craig Miller,Eugene H. Blackstone,Michael J. Mack,Lars G. Svensson,Susheel Kodali,Samir R. Kapadia,Jeevanantham Rajeswaran,William N. Anderson,Jeffrey W. Moses,E. Murat Tuzcu,John G. Webb,Martin B. Leon,Craig R. Smith +12 more
TL;DR: There were 2 distinct hazard phases for neurologic events that were driven by different risk factors after either treatment, but thereafter the risk was influenced by patient- and disease-related factors.